Citations 1
Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results.
Villalobos, Víctor M. , Tine, Brian Andrew Van, Dickson, Mark A. , Cronier, Damien M., Attia, Steven , Redondo, Andrés , Schwartz, Gary K. , Chmielowski, Bartosz , Peterson, Patrick M. , Wright, Jennifer
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11542-11542
